This Startup Raised $5.2 Million To Develop Blood Tests For Cancer

Predicta Biosciences is using precision medicine to diagnose and monitor multiple myeloma–and give doctors insights for better treatment plans.

Related Posts

Apple’s Own Black Friday Event iPhone 15 And iPad Offer...

risingforbes Nov 29, 2024  0  1

2 Signs Your Partner Eases Your ‘Appearance Anxiety’—By...

risingforbes Nov 18, 2024  0  0

What Good Is The Office Now Anyways?

risingforbes Oct 22, 2023  0  2

Comments

Name

Email

Comment

Post Comment